Koers Purple Biotech Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
PPBT
IL0007650166
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 14,01 mln. 51,92 mln. 13,02 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -13 mln. -48,16 mln. -12,08 mln. | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,59% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gil Efron
CEO | Chief Executive Officer | 57 | 11-10-18 |
Lior Fhima
DFI | Director of Finance/CFO | - | 02-11-22 |
Ido Morpurgo
COO | Chief Operating Officer | 51 | 01-08-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eric Rowinsky
CHM | Chairman | 67 | 02-10-19 |
Yael Margolin
BRD | Director/Board Member | 70 | 20/12 |
Simcha Rock
BRD | Director/Board Member | 73 | 11-07-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,96% | 105 mld. | |
-1,43% | 104 mld. | |
+4,40% | 22,94 mld. | |
-12,15% | 22,34 mld. | |
-4,36% | 19,25 mld. | |
-39,98% | 17,08 mld. | |
-10,04% | 16,96 mld. | |
+38,61% | 12,63 mld. | |
+313,59% | 8,49 mld. |